Kao HF, Huang HC, Liao BC, Hong RL, et al. Short-course pembrolizumab and continuous afatinib therapy for recurrent or metastatic head and neck squamous cell carcinoma: a real-world data analysis. BMC Cancer 2022;22:1228.
PMID: 36443704